Cancer-preventing vaccination programs in prison: promoting health equity in Europe
Cancer-preventing vaccination programs in prison: promoting health equity in Europe
The most important human oncogenic viruses are hepatitis B virus (HBV) and human papillomavirus (HPV). The roll-out of vaccinations against HPV and HBV is a significant public health initiative with robust evidence of impact on the prevention of infection and neoplastic disease sequelae. Incarcerated individuals frequently have suboptimal immunisation levels for a wide variety of vaccine-preventable diseases, including HBV and HPV, and a high burden of disease for HBV/HPV-related cancers. In this Personal View, we analyse evidence regarding HBV and HPV vaccination in prison settings in 20 European countries and integrate it with existing scientific literature to discuss the rationale and possible strategies to expand cancer-preventing vaccination in prison populations. Enhancing HBV/HPV vaccination offer and uptake of HBV/HPV vaccination for this population would not only contribute to reducing the derived burden among the European population, but would also foster health equity and boost efforts towards the attainment of global and regional public health targets.
Cocco, Nicola
eefa7ec0-8abe-4fba-b96e-f65cfc701a4b
Fantozzi, Maria Paula
598e45cd-df03-46b0-afea-602f62065b15
Ihuthia, Josephine Njeri
38dbae8a-f83e-406b-8dc9-e79237f555f6
Moazen, Babak
74146d47-75ee-4644-bb6e-22179b892bf0
Meroueh, Fadi
b57a5dea-174e-4512-82c9-5e8374a58fcc
Barbiros, Irina
dda10ba4-b757-4529-8a4c-76e54124d276
Mavrou, Josephina
e1e8244f-0bb2-48c2-8257-ec40a9fec9da
Bardelli, Angela
1b592715-0fea-4e51-afae-d3eac9218747
De Vita, Erica
320e751b-5ab8-429e-a8b5-38fbe7caa416
Plugge, Emma
b64d2086-6cf2-4fae-98bf-6aafa3115b35
Tavoschi, Lara
7afb4e1d-dc8c-481f-af69-dfa933d40e48
1 August 2024
Cocco, Nicola
eefa7ec0-8abe-4fba-b96e-f65cfc701a4b
Fantozzi, Maria Paula
598e45cd-df03-46b0-afea-602f62065b15
Ihuthia, Josephine Njeri
38dbae8a-f83e-406b-8dc9-e79237f555f6
Moazen, Babak
74146d47-75ee-4644-bb6e-22179b892bf0
Meroueh, Fadi
b57a5dea-174e-4512-82c9-5e8374a58fcc
Barbiros, Irina
dda10ba4-b757-4529-8a4c-76e54124d276
Mavrou, Josephina
e1e8244f-0bb2-48c2-8257-ec40a9fec9da
Bardelli, Angela
1b592715-0fea-4e51-afae-d3eac9218747
De Vita, Erica
320e751b-5ab8-429e-a8b5-38fbe7caa416
Plugge, Emma
b64d2086-6cf2-4fae-98bf-6aafa3115b35
Tavoschi, Lara
7afb4e1d-dc8c-481f-af69-dfa933d40e48
Cocco, Nicola, Fantozzi, Maria Paula, Ihuthia, Josephine Njeri, Moazen, Babak, Meroueh, Fadi, Barbiros, Irina, Mavrou, Josephina, Bardelli, Angela, De Vita, Erica, Plugge, Emma and Tavoschi, Lara
,
the RISE-Vac Consortium
(2024)
Cancer-preventing vaccination programs in prison: promoting health equity in Europe.
The Lancet Regional Health – Europe, 43, [100958].
(doi:10.1016/j.lanepe.2024.100958).
Abstract
The most important human oncogenic viruses are hepatitis B virus (HBV) and human papillomavirus (HPV). The roll-out of vaccinations against HPV and HBV is a significant public health initiative with robust evidence of impact on the prevention of infection and neoplastic disease sequelae. Incarcerated individuals frequently have suboptimal immunisation levels for a wide variety of vaccine-preventable diseases, including HBV and HPV, and a high burden of disease for HBV/HPV-related cancers. In this Personal View, we analyse evidence regarding HBV and HPV vaccination in prison settings in 20 European countries and integrate it with existing scientific literature to discuss the rationale and possible strategies to expand cancer-preventing vaccination in prison populations. Enhancing HBV/HPV vaccination offer and uptake of HBV/HPV vaccination for this population would not only contribute to reducing the derived burden among the European population, but would also foster health equity and boost efforts towards the attainment of global and regional public health targets.
Text
1-s2.0-S266677622400125X-main
- Version of Record
More information
Accepted/In Press date: 27 May 2024
e-pub ahead of print date: 19 June 2024
Published date: 1 August 2024
Identifiers
Local EPrints ID: 493451
URI: http://eprints.soton.ac.uk/id/eprint/493451
ISSN: 2666-7762
PURE UUID: c91ea16c-86d9-4ab9-8412-1b1a0736325e
Catalogue record
Date deposited: 03 Sep 2024 16:43
Last modified: 04 Sep 2024 02:00
Export record
Altmetrics
Contributors
Author:
Nicola Cocco
Author:
Maria Paula Fantozzi
Author:
Josephine Njeri Ihuthia
Author:
Babak Moazen
Author:
Fadi Meroueh
Author:
Irina Barbiros
Author:
Josephina Mavrou
Author:
Angela Bardelli
Author:
Erica De Vita
Author:
Lara Tavoschi
Corporate Author: the RISE-Vac Consortium
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
